Availability of Temgesic® Sublingual Tablets

HPS Pharmacies wish to advise that Echo Therapeutics are experiencing a supply interruption for Temgesic^® sublingual tablets as follows:

Temgesic^® Sublingual Tablets
Buprenorphine 200 microgram
ARTG 34091

This supply interruption currently only affects the 50-pack of sublingual tablets. Normal supplies of this product are expected to resume by the end of August 2025.

An internationally registered alternative of the 50-pack has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. This product is registered in Germany and labelling is in German. The strength is printed on the outer carton, but not on individual blisters, which may lead to confusion. To avoid this issue, the Australian-registered pack of 20 sublingual tablets may be considered, where appropriate.

Please note that S19A products may have a longer lead time as they must be sourced internationally.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Echo Therapeutics on 1300 848 328, or your pharmacist at HPS Pharmacies.

Download PDF